in Newswire November 15, 2019

Two Women File Class Action After Study Exposes Ineffectiveness of Preterm Birth Drug Makena

by Erin Shaak

Last Updated on November 15, 2019

Faughnan et al. v. AMAG, Inc.

Filed: November 12, 2019 § 3:19-cv-01394

A lawsuit filed against Makena manufacturer AMAG, Inc. claims the “exorbitantly-priced” preterm birth medication is “no more effective than a placebo.”


AMAG, Inc.



New York

Last Updated on November 15, 2019 — 4:11 PM

Erin Shaak

Erin works primarily on’s newswire, reporting on cases as they happen.

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.